Quality Control of Radiopharmaceuticals

  • Gopal B. Saha


Since radiopharmaceuticals are intended for human administration, it is imperative that they undergo strict quality control measures. Basically, quality control involves several specific tests and measurements that ensure the purity, potency, product identity, biologic safety, and efficacy of radiopharmaceuticals. All quality control procedures that are applied to nonradioactive pharmaceuticals are equally applicable to radiopharmaceuticals; in addition, tests for radionuclidic and radiochemical purity have to be carried out. Often these quality control tests are carried out by the manufacturers from the beginning of production all the way up to the finished product. However, the introduction of kits, the increasing use of short-lived radionuclides such as 99mTc and 113mIn, and the on-site preparation of many radiopharmaceuticals require that most, if not all, quality control tests be performed prior to dispensing these agents for human administration.


Radiochemical Purity Limulus Amebocyte Lysate Quality Control Test Dose Calibrator Radionuclidic Purity 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Suggested Reading

  1. Avis KE (1970) Parenteral preparations. In: Remington’s pharmaceutical sciences, 14th ed, Mack, Easton, Pa, p 1519Google Scholar
  2. Billinghurst MW (1973) Chromatographic quality control of 99mTc-labeled compounds. J Nucl Med 14: 793PubMedGoogle Scholar
  3. Bobinet DD, Williams GC, Cohen MB (1976) Comparison of commercial pyrogen testing laboratories. Am J Hosp Pharm 33: 801PubMedGoogle Scholar
  4. Chandler RP (1977) A micro-thin-layer chromatography method for radiopharmaceuticals. Appl Radiol 6: 216Google Scholar
  5. Cohen Y (1966) Chemical and radiochemical purity of radioactive pharmaceuticals related to their biological behavior. In: Radioactive pharmaceuticals, CONF-561111. US Atomic Energy Commission, Oak Ridge, p 67Google Scholar
  6. Eckelman WC, Levenson SM, Johnston GS (1977) Radiochemical purity of 99mTc radiopharmaceuticals. Appl Radiol 6: 211Google Scholar
  7. Krogsgaard OW (1976) Radiochemical purity of various 99mTc-labelled bone-scanning agents. Eur J Nucl Med 1: 15PubMedGoogle Scholar
  8. Pauwels EKJ, Feitsma RIJ (1977) Radiochemical quality control of 99mTc-labeled radiopharmaceuticals. Eur J Nucl Med 2: 97PubMedCrossRefGoogle Scholar
  9. Rhodes BA (ed) (1977) Quality control in nuclear medicine. Mosby, St Louis, Sect 3, Chap 17–33Google Scholar
  10. Saha GB, Fairer PA (1975) Principles of radiopharmacology in the practice of nuclear medicine. Fundamental aspects: Part II. Can J Radiogr Radiother Nucleogr 6: 230Google Scholar
  11. Stelmach HA, Quinn JL (1974) Radiopharmaceutical quality control. Semin Nucl Med 4:295PubMedCrossRefGoogle Scholar
  12. Subramanian G, Rhodes BA, Cooper JF, Sodd VJ (eds) (1975) Radiopharmaceuticals. Society of Nuclear Medicine, New York, Chap 23–27Google Scholar
  13. Tubis M (1978) Quality control of radiopharmaceuticals. In: Rocha AFG, Harbert JC (eds) Textbook of nuclear medicine: Basic science. Lea & Febiger, Philadelphia, p 234Google Scholar
  14. U.S. Pharmacopeia XX. United States Pharmacopeial Convention, Rockville, Md (1980)Google Scholar

Copyright information

© Springer Science+Business Media New York 1984

Authors and Affiliations

  • Gopal B. Saha
    • 1
  1. 1.College of PharmacyUniversity of New MexicoAlbuquerqueUSA

Personalised recommendations